This study is the first to highlight high rates of prescribing drugs for psychosis with clinical recommendations based on the CYP2D6 genotype in EIP services, yet PGx testing to determine the CYP2D6 genotype is not available in EIP settings. This evidence concerns the gene CYP2D6 and psychotic disorder.